Portfoliotracker

Nyxoah SA

NYXH.BR · BRUSSELS · Healthcare Medical Devices 6/100 E

0,815 €
▲ +0,008 (+0,99 %)
Trading delayed by 15 min
Price as of 17. 11. 13:51, fetched 17. 11. 14:43
Next earnings–
Ex-dividend–
Analysts–
50 / 200 day average– / –

Price

Portfoliotracker score6 / 100 Market cap46,0 mil. € P/E– Forward P/E-1,6 P/S2,1 P/B0,6 EV/EBITDA– Dividend yield– FCF yield-164,25 % EPS-1,55 € Net margin0,0 % Return on equity-151,8 % Beta1,02 Debt / equity0,79
52-week range 0,70 to 4,74
3-month average volume0,2 M

Finance

Where the revenue goes

Loading the income statement flow…

Fundamentals

Loading key figures…

Insiders, analysts and people

All trades and changes

Loading insiders, analysts and opinions…

Co se právě děje

AI souhrn
Objednat AI souhrn, co se u firmy právě děje Vytvoří se jednou na pozadí a pak ho uvidí všichni. Ve verzi Free 3 objednávky měsíčně.

About the company

Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat obstructive sleep apnea. Its lead solution is the Genio system, a hypoglossal neurostimulations therapy for obstructive sleep apnea. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.

Website
nyxoah.com
Employees
153
Country
Belgium
Data since
18. 9. 2020

Explore further

Similar companies HYL.BRARGX.BRONTEX.BR

Intraday chart

Your own portfolio, properties and finances in one place.

The account is free with no time limit. Only you see your data; nobody adds it up with others.

This is saved to your account. You can keep browsing, calculating and comparing without signing in.

Welcome back

Sign in and pick up where you left off.

or continue with

No account yet? Create a free account